Analytical method cross validation by HPLC for identification of five markers and quantification of one marker in SynacinnTM formulations and its in vivo bone marrow micronucleus test data

Abstract

A HPLC method has been validated for identifying five markers (gallic acid, rosmarinic acid, catechin, andrographolide and curcumin) and quantifying curcumin in Synacinn TM formulation. The validation (bracketed strengths of 10 mg/mL and 100 mg/mL) involved assessment of selectivity, precision, Limit of Detection (LOD), Limit of Quantification (LOQ), linearity, accuracy, stability in diluent and formulation stability. Meanwhile, in vivo bone marrow micronucleus test data was presented to evaluate the toxicity potential of Synacinn™ to cause clastogenicity and/or disruption of the mitotic apparatus, as measured by its ability to induce micronucleated polychromatic erythrocytes (MN PCE) in Sprague Dawley rat bone marrow. The test was conducted in two phases viz., Phase I (Dose Range Finding experiment) and Phase II (Definitive experiment). Phase I was conducted to assess general toxicity and bone marrow cytotoxicity of Synacinn™, and to select the doses for the definitive experiment. In-life observations included mortality, clinical signs of toxicity and body weight. Bone marrow samples were collected and extracted from the femur bone using fetal bovine serum. The pellet obtained after the centrifugation was used for preparing bone marrow smears to evaluate the number of immature and mature erythrocytes.

Gel formulated with Bryophyllum pinnatum leaf extract promotes skin wound healing in vivo by increasing VEGF expression: A novel potential active ingredient for pharmaceuticals

“…The association of TPC and TFC per gram of gel formulation is a required parameter to ensure the safety, efficacy, quality, and batch-to-batch reproducibility of the final products. Few data about the quantification of markers in a formulation containing botanical extracts ( Zainol et al, 2021 ) have been reported in the literature.…”

Mutagenicity and safety pharmacology of a standardized antidiabetic polyherbal formulation

“…The in vivo test was conducted and designed based on the ICH S2 (R1) and OECD guidelines 33 , 38 , 39 . A stratified randomized design (Microsoft Excel ® ) was used in the grouping and allocation of healthy rats (age of 8–10 weeks) to the respective treatment.…”

Anti-Inflammatory and Oral Toxicity Assessment of R-38tm: A Traditional Herbal Supplement for Arthritis

“…Approximately 2.0 mg of R-38 TM water extract was dissolved in 1 mL of 50% methanol (v/v; methanol in water) and vortexed for 5 min. The standard stock solution of rosmarinic acid was prepared by dissolving 2.0 mg in 1 mL of 50% methanol and vortexed for 5 min [29]. Five working standard solutions with a concentration of 20, 50, 100, 200, and 500 parts per million (ppm) were prepared from the stock solution.…”